Martin Shkreli

She said CEO Martin Shkreli should "do the right thing."
CEO Martin Shkreli didn't say how much he'd cut the cost of Daraprim.
Martin Shkreli is part of a federal probe involving a biotech company that fired him last year.
A bracing reminder that jacking up drug prices is perfectly legal.